Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

PURE Bioscience, Inc. (PURE)

-Other OTC
1.20 Up 0.02(1.69%) Apr 17, 3:59PM EDT
Get the big picture on all your investments.
ProfileGet Profile for:
PURE Bioscience, Inc.
1725 Gillespie Way
El Cajon, CA 92020
United States - Map
Phone: 619-596-8600
Fax: 619-596-8790
Website: http://www.purebio.com

Details 
Index Membership:N/A
Sector:Basic Materials
Industry:Chemicals - Major Diversified
Full Time Employees:13

Business Summary 

PURE Bioscience, Inc. is engaged in developing antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control. The company manufactures and distributes silver dihydrogen citrate based disinfecting and sanitizing products. Its technology platform is based on an electrochemical process that allows generating ionized silver in the presence of organic acid. The company’s products include PURE Hard Surface, a hard surface disinfectant and food contact surface sanitizer for use in food processing equipment, machinery, and utensils; PURE Multi-Purpose Cleaner, an environmentally cleaning product for use in various resilient surfaces, including floors, glass, and food contact surfaces; and Axen30, a hard surface disinfectant. Its products also comprise Axenohl, an antimicrobial formulation used as a raw material in the manufacturing of environmental protection agency-registered products; and Silvérion, an antimicrobial formulation used as a raw material in the manufacturing of personal care products. Pure Bioscience, Inc. markets and sells its products primarily to distributors and end users in the United States and internationally. The company was formerly known as PURE Bioscience and changed its name to Pure Bioscience, Inc. in March 2011. Pure Bioscience, Inc. was founded in 1992 and is headquartered in El Cajon, California.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on PURE Bioscience, Inc.

Key Executives 
 PayExercised
Mr. Peter C. Wulff , 55
Chief Financial Officer, Chief Operating Officer and Corp. Sec.
156.00K0.00
Mr. Henry R. Lambert , 63
Chief Exec. Officer and Director
N/AN/A
Mr. Tom Myers ,
Exec. VP of Marketing and Product Devel.
N/AN/A
Mr. Cliff Wechsler ,
Exec. VP of Sales
N/AN/A
Mr. Don Markley ,
Sr. VP
N/AN/A
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders